Solara Active Pharma Sciences has completed sale of 100% shareholding in SeQuent Penems to M/s. Symbio Generrics India on April 25, 2024. Hence, SeQuent Penems ceased to be a subsidiary of the Company. The board of directors of the company at its meeting held on March 25, 2024 approved the same.
Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer.